[Effect of quateron on the dopamine and DOPA content in brain and adrenal tissues in experimental gastric ulcer].
D000311:Adrenal Glands / Q000378:metabolism*; D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004353:Drug Evaluation, Preclinical; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
D000897:Anti-Ulcer Agents; D001565:Benzoates; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D004295:Dihydroxyphenylalanine; D004298:Dopamine
Vliianie kvaterona na soderzhanie dofamina i DOFA v tkaniakh mozga i nadpochechnikov pri éksperimental'noĭ iazve zheludka.